We clearly are not treating one specific XMRV, at least not the chimera created in Dr. Silverman's lab in the process of looking for the one specific virus. From the studies to date, it does seem clear that VP62 or anything very close to that is not our problem.It is unfortunate that Dr. Judy Mikovits does not publish these claims herself, so we will have to do with what Jamie Deckoff-Jones MD has to say in that matter.
And again, this is what the Lombardi et al study had to say, where Dr. Judy Mikovits was principal:
In all positive cases, the XMRV gag and env sequences were more than 99% similar to those previously reported for prostate tumor–associated strains of XMRV (VP62, VP35, and VP42) (fig. S1)So to dispel any confusion, I created a little infographic, explaning the current Mikovits/XMRV/VP62 defense, as used by Jamie Deckoff-Jones MD:
So when the WPI published sequences in June and August 2011 without Silverman's involvement, they turned up to be still VP62 – go run BLAST on them for yourself.
Hope this clears up things a bit.